McKesson’s Z-Code™ Identifiers came into the clinical lab and pathology spotlight when Palmetto GBA, the Medicare contractor for California, Nevada, Hawaii, and U.S. Pacific territories, last year began requiring their use in its controversial MolDx program, under which Palmetto determines coverage and payment for molecular pathology tests. That program is run under a separate contract…

This content is for Paid Members only.
Login Register